These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11933461)
1. [Role of the MIB-1 proliferative markers in the diagnosis and prognosis of tumors of the thyroid gland]. Ludvíková M; Ryska A; Hovorková E; Pikner R Cesk Patol; 2002 Jan; 38(1):4-10. PubMed ID: 11933461 [TBL] [Abstract][Full Text] [Related]
2. Proliferative markers in diagnosis of thyroid tumors: a comparative study of MIB-1 and topoisomerase II-a immunostaining. Ludvíková M; Holubec L; Ryska A; Topolcan O Anticancer Res; 2005; 25(3A):1835-40. PubMed ID: 16033110 [TBL] [Abstract][Full Text] [Related]
3. MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland. Rickert D; Mittermayer C; Lindenfelser R; Biesterfeld S Anal Quant Cytol Histol; 2000 Jun; 22(3):229-34. PubMed ID: 10872040 [TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry]. Guyétant S; Michalak S; Valo I; Saint-André JP Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis and proliferative activity in thyroid tumors. Yoshida A; Nakamura Y; Imada T; Asaga T; Shimizu A; Harada M Surg Today; 1999; 29(3):204-8. PubMed ID: 10192728 [TBL] [Abstract][Full Text] [Related]
6. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634 [TBL] [Abstract][Full Text] [Related]
7. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687 [TBL] [Abstract][Full Text] [Related]
8. [The use of immunohistochemistry in the differential diagnosis of thyroid gland tumors with follicular growth pattern]. Laco J; Ryska A Cesk Patol; 2006 Jul; 42(3):120-4. PubMed ID: 16955558 [TBL] [Abstract][Full Text] [Related]
9. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma. Tan A; Etit D; Bayol U; Altinel D; Tan S Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633 [TBL] [Abstract][Full Text] [Related]
10. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Vargas MP; Vargas HI; Kleiner DE; Merino MJ Mod Pathol; 1997 Jan; 10(1):12-7. PubMed ID: 9021722 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of CD15, galectin-3 and HBME-1 expression in follicular thyroid neoplasms]. Bogdańska M; Górnicka B; Ziarkiewicz-Wróblewska B; Koperski L; Morton M; Wasiutyński A Endokrynol Pol; 2006; 57(4):314-9. PubMed ID: 17006830 [TBL] [Abstract][Full Text] [Related]
12. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid. Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277 [TBL] [Abstract][Full Text] [Related]
14. Role of Ki-67 as a proliferative marker in lesions of thyroid. Pujani M; Arora B; Pujani M; Singh SK; Tejwani N Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907 [TBL] [Abstract][Full Text] [Related]
15. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases. Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy. Sofiadis A; Tani E; Foukakis T; Kjellman P; Skoog L; Höög A; Wallin G; Zedenius J; Larsson C Int J Oncol; 2009 Aug; 35(2):369-74. PubMed ID: 19578751 [TBL] [Abstract][Full Text] [Related]
17. Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy. Mehrotra P; Gonzalez MA; Johnson SJ; Coleman N; Wilson JA; Davies BR; Lennard TW Laryngoscope; 2006 Aug; 116(8):1434-8. PubMed ID: 16885749 [TBL] [Abstract][Full Text] [Related]
18. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. Bernet VJ; Anderson J; Vaishnav Y; Solomon B; Adair CF; Saji M; Burman KD; Burch HB; Ringel MD J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475 [TBL] [Abstract][Full Text] [Related]
19. Proliferative activity in thyroid tumors. Yoshida A; Kamma H; Asaga T; Masuzawa C; Kawahara S; Mimura T; Ito K Cancer; 1992 May; 69(10):2548-52. PubMed ID: 1568178 [TBL] [Abstract][Full Text] [Related]
20. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors. Sigstad E; Paus E; Bjøro T; Berner A; Grøholt KK; Jørgensen LH; Sobrinho-Simões M; Holm R; Warren DJ Mod Pathol; 2012 Apr; 25(4):537-47. PubMed ID: 22157935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]